Carregant...
Combinatorial approach to cancer immunotherapy: strength in numbers
Immune‐checkpoint blockade therapy with antibodies targeting CTLA‐4 and PD‐1 has revolutionized melanoma treatment by eliciting responses that can be remarkably durable and is now advancing to other malignancies. However, not all patients respond to immune‐checkpoint inhibitors. Extensive preclinica...
Guardat en:
| Publicat a: | J Leukoc Biol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6608090/ https://ncbi.nlm.nih.gov/pubmed/27256570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1189/jlb.5RI0116-013RR |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|